MAX Surgical Specialty Management Overhauls Leadership for Northeast Expansion

Since its inception in 2022, the Hackensack-based organization has scaled to support over 50 surgeons across 40 locations in New Jersey, New York, Pennsylvania, Connecticut, and Vermont. The new structure divides responsibilities to emphasize both clinical culture and administrative efficiency. Auerbach will retain focus on the clinical and cultural development of the platform, while DeBellis takes charge of the operational infrastructure required to sustain rapid growth. Jeffrey Couper remains in his position as Chief Financial Officer to oversee the company’s scaling financial strategy.

This management evolution arrives with the continued backing of MedEquity Capital, RF Investment Partners, and Kian Capital. The investors emphasize that the company’s growth model relies on providing institutional-grade support—covering human resources, revenue cycle management, and compliance—without compromising the clinical autonomy of independent practices. By refining its executive roles, MAX intends to standardize the onboarding of new partner practices while maintaining the surgical identity of its network.